OTCMKTS:BNKL Bionik Laboratories (BNKL) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock AnalysisChartSEC FilingsBuy This Stock About Bionik Laboratories Stock (OTCMKTS:BNKL) 30 days 90 days 365 days Advanced Chart Get Bionik Laboratories alerts:Sign Up Key Stats Today's Range N/A50-Day Range N/A52-Week Range N/AVolumeN/AAverage Volume1 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Bionik Laboratories is a medical device company focused on the development and commercialization of robotic-based therapies for rehabilitation and mobility restoration. The company’s core products include the InMotion ARM and InMotion Hand systems, which provide targeted robotic-assisted therapy for upper limb rehabilitation in patients recovering from stroke, spinal cord injuries and other neurological disorders. Bionik leverages advanced software, sensors and machine learning to deliver personalized treatment protocols and track patient progress in real time. Expanding beyond upper limb solutions, Bionik introduced the ARKE lower extremity exoskeleton to support gait training and balance recovery, as well as the REX Robotic Exoskeleton for upright mobility in individuals with severe lower limb disabilities. These devices are designed to restore functional independence and improve overall quality of life by enabling repetitive, high-intensity therapeutic movements that are difficult to achieve through traditional therapy alone. Integrating hardware, software and clinical data, Bionik’s platforms adapt dynamically to each user’s needs. Bionik collaborates with rehabilitation centers, hospitals and research institutions to validate and refine its technologies, contributing to clinical research and publishing outcomes that demonstrate enhanced patient engagement and functional gains. Through strategic partnerships and ongoing innovation, the company aims to transform standard rehabilitation practices and expand access to advanced, data-driven therapeutic solutions for individuals with neurological impairments. By combining robotics expertise with medical insights, Bionik seeks to accelerate recovery pathways and deliver better long-term outcomes for patients worldwide.AI Generated. May Contain Errors. Read More Receive BNKL Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Bionik Laboratories and its competitors with MarketBeat's FREE daily newsletter. Email Address BNKL Stock News HeadlinesBMND:CA Biomind Labs Inc.August 28, 2024 | seekingalpha.comGlobal Neurorehabilitation Devices Market Size To Exceed USD 6.2 Billion By 2033 | CAGR Of 12.55%May 27, 2024 | finance.yahoo.comGold is soaring. Here’s how to get paid from itGold just broke through $3,300… And while the headlines shout about price targets, something even more powerful is happening behind the scenes… Some investors are using a little-known ETF to collect up to $1,152/month from gold's surge. No trading gold futures. No mining stocks. No vaults. Just a simple fund delivering monthly payouts — like clockwork. | Investors Alley (Ad)Want a more immersive Xbox gaming experience? The Bionik Pro Kit+ is only $40!April 26, 2024 | msn.comCharles River Laboratories (CRL)February 27, 2024 | investing.comSilicon Laboratories Inc.January 30, 2024 | wsj.comFirst human eggs grown in laboratoryDecember 14, 2023 | bbc.comBDr. Reddy's LaboratoriesOctober 28, 2023 | forbes.comSee More Headlines BNKL Stock Analysis - Frequently Asked Questions How do I buy shares of Bionik Laboratories? Shares of BNKL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Bionik Laboratories own? Based on aggregate information from My MarketBeat watchlists, some other companies that Bionik Laboratories investors own include Ashford Hospitality Trust (AHT), Assertio (ASRT), Peabody Energy (BTU), Co-Diagnostics (CODX), Adamis Pharmaceuticals (ADMP), PlayAGS (AGS) and Ardmore Shipping (ASC). Company Calendar Today7/12/2025Fiscal Year End3/31/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry MED INSTRUMENTS Sub-IndustryMedical Equipment Current SymbolOTCMKTS:BNKL CIK1508381 Webwww.bioniklabs.com Phone(617) 926-4800FaxN/AEmployees10Year FoundedN/AProfitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual Sales$1.80 million Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A Social Links 7 Stocks to Buy And Hold ForeverEnter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising. Get This Free Report This page (OTCMKTS:BNKL) was last updated on 7/12/2025 by MarketBeat.com Staff From Our PartnersI was wrong about TrumpI made a mistake. A mistake I feel very foolish about. After speaking with Donald Trump and some of his ...Porter & Company | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | SponsoredTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredTrump’s whole-government AI plans leakedThe New Elon Musk is officially stepping back from his day-to-day duties with DOGE. At least, that's the s...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bionik Laboratories Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Bionik Laboratories With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.